Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Auto
    • Real Estate
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Health»BIBO Health Offers Hope for Millions Battling Breathing Troubles in India
    Health

    BIBO Health Offers Hope for Millions Battling Breathing Troubles in India

    By October 19, 2023No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), October 19: In a country where over 200 million people grapple with frequent breathing difficulties, the traditional Indian system of medicine, Ayurveda, is being looked at as a ray of hope. Among the pioneers in this endeavour is Bibo Health, a company that is gaining recognition in the market for its groundbreaking Ayurvedic formulations. With over 400,000 satisfied customers in the past three years, Bibo has carved a niche for itself by introducing unique, natural solutions to respiratory problems. The brand name itself is an acronym for ‘Breathe in, breathe out’ and truly represents respiratory wellness. 

    Ayurveda, the ancient Indian system of holistic medicine, has been gaining prominence for its natural and sustainable approach to healthcare. BIBO Health has harnessed the power of Ayurveda to create formulations that are pathbreaking not only in India but also on a global scale. One of their remarkable achievements are in treating chronic respiratory conditions, which has been documented and published in prestigious journals such as the International Ayurvedic Medical Journal (IAMJ). 

    One of the star products of BIBO is their Saline Nasal Spray enriched with Tulsi (holy basil) and Xylitol. This innovation has been recognized for its potent anti-inflammatory and immunomodulatory properties. Tulsi, a revered herb in Ayurveda, has been proven to offer a natural and effective means of combating respiratory issues. The company’s commitment to holistic well-being is evident in its unrelenting stance against the excessive use of allopathic medicines for respiratory problems. Frequent and indiscriminate use of allopathic medications can lead to adverse health effects and is not conducive to self-medication.

    BIBO Health’s Ayurvedic solutions are rooted in the principles of traditional medicine and seek to provide safer alternatives to those suffering from chronic respiratory conditions. 

    BIBO Health has also made a significant impact on the scientific and medical community. Their research papers, featured in reputable journals detail the development and efficacy of their Ayurvedic formulations. These publications not only highlight the potential benefits of herbs, but also provide insights into the future of Ayurvedic healthcare. One of the recent milestones achieved by BIBO Health is the rollout of their product-patent pending formulation for Saline Nasal Spray with Tulsi and Xylitol. This innovation promises to further elevate the company’s contribution to the field of respiratory health and offers hope to millions of individuals in India and around the world who struggle with breathing issues. 

    In a world that is increasingly seeking natural and holistic solutions to health problems, BIBO Health aims to provide Ayurvedic answers to respiratory troubles that have long plagued a significant portion of the Indian population. With a track record of success their products and research results are proof of the immense potential of Ayurveda in addressing the pressing health concerns of our time. 

    Note: The prevalence of chronic respiratory illnesses in India is comparatively higher. COPD itself affects 5.5% of the overall population which makes about 7 Cr (70 million) people. Moreover, sinusitis and frequent common cold is pervasive too. Every 1 in 5 individuals in urban India has either Sinusitis, Asthma, or COPD. 

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    ’70–80% of Medical Issues Don’t Need Hospitalization’ — Ashish Srivastava’s Visionary Day-Care Model

    July 13, 2026

    AI Progress in Healthcare: How Intelligent Technology Is Transforming Patient Care

    July 7, 2026

    You’re Not Deficient. Your Diet Just Has Gaps.

    July 1, 2026

    Comments are closed.

    Recent Post
    • What If Movies Could Smell and Taste? The Future of Digital Flavor and Sensory Cinema
    • Automation Expo 2026 to Spotlight AI, Smart Manufacturing, and Industrial Innovation in Mumbai
    • Chandan Healthcare Limited Q1 FY27 Operational Update: Operating Income Up 35.64% YoY to ₹48.67 Cr; Pharmacy Up 13.69% YoY to ₹32.33 Cr
    • YAAP Digital Announces Leadership Transition; Appoints Raj Nayak as Chairman & Managing Director
    • BIRLA AIRCON Earns Bureau of Indian Standards Appreciation for Quality Excellence, Records Over 700% Growth
    • Rotoris Celebrates Neeru Dhanda’s Historic ISSF World Cup Gold, Honouring the Power of Belief, Conviction and Invisible Work
    • UniHealth Launches Comprehensive Eye Care and Ophthalmology Services at UMC Victoria Hospital, Uganda
    • Vivid Electromech Reports 36% YoY Revenue Growth in Q1 FY27; Order Pipeline Strong at Rs 210 Cr

    Type above and press Enter to search. Press Esc to cancel.